Teva meets investors for first Israeli corporate bond
Teva Pharmaceutical Industries kicks off investor meetings in Europe next week. The borrower is looking to issue its first euro denominated bond since 2012.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts